Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00681759 · ClinicalTrials.gov registry record
An Observational Study of Burden of Upper GI-Symptoms in CV Risk Patients
A clinical trial, sponsored by AstraZeneca.
- Completed
- Registry status
- 1,836
- Enrollment target
NCT00681759 is a clinical trial that has completed, run by AstraZeneca. The registered enrollment target is 1,836 participants.
The verdict
NCT00681759 has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- 1,836 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the burden of upper gastrointestinal symptoms in patients with cardiovascular disease taking low dose aspirin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,836 participants |
| Start Date | 2008-01 |
| Est. Completion | 2008-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00681759
The ClinicalTrials.gov registry entry for NCT00681759 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,836 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00681759 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00681759 about?
NCT00681759 is a clinical study titled "An Observational Study of Burden of Upper GI-Symptoms in CV Risk Patients". The purpose of this study is to investigate the burden of upper gastrointestinal symptoms in patients with cardiovascular disease taking low dose aspirin
What is the current status of trial NCT00681759?
This trial is currently completed. The enrollment target is 1,836 participants. The study started on 2008-01. Estimated completion is 2008-09.
Who is sponsoring clinical trial NCT00681759?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.